Write For Us

Dr. David Solit | A big data approach to identifying new cancer drug targets

E-Commerce Solutions SEO Solutions Marketing Solutions
167 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

lily
Published
Physician-scientist David Solit focuses on the development of cancer therapies that target pathways responsible for cancer initiation and progression. Dr. Solit is the Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology (CMO), Memorial Sloan Kettering’s new collaborative center that is undertaking a wide-ranging effort to correlate tumor genetics with clinical outcomes and responses to therapy. He is also a member of the Human Oncology and Pathogenesis Program, where his laboratory team works to identify novel drug targets.
Category
Comment
Sign in or sign up to post comments.
Be the first to comment

Up Next